The aim of this study is to assess the effects of MCR agonist NDP-α-MSH in two transgenic mouse models of AD, 5XFAD and 3xTg mice, that markedly differ as regards the relationship between cognitive alterations and neuropathology. Here, NR3C2 is linked to Alzheimer disease.